TISSUE MMP-7 EXPRESSION PREDICTS SURVIVAL IN BLADDER CANCER PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY

被引：2
|
作者：
Szarvas, Tibor
Kramer, Gero
Hess, Jochen
Tschirdewahn, Stephan
Reis, Henning
Romics, Imre
Sevcenco, Sabina
Toetsch, Martin
Ruebben, Herbert
Dorp, Frank Vom
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1867
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1416
引用
收藏
页码：E575 / E575
页数：1
相关论文
共 50 条
  • [21] Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
    Keck, Bastian
    Wach, Sven
    Stoehr, Robert
    Kunath, Frank
    Bertz, Simone
    Lehmann, Jan
    Stoeckle, Michael
    Taubert, Helge
    Wullich, Bernd
    Hartmann, Arndt
    BMC CANCER, 2013, 13
  • [22] ACCELERATED CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER
    BOSHOFF, C
    OLIVER, RTD
    GALLAGHER, CJ
    ONG, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1633 - 1636
  • [23] Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
    Bastian Keck
    Sven Wach
    Robert Stoehr
    Frank Kunath
    Simone Bertz
    Jan Lehmann
    Michael Stöckle
    Helge Taubert
    Bernd Wullich
    Arndt Hartmann
    BMC Cancer, 13
  • [24] Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer
    Liu, Hui
    Zhang, Tiantuo
    Li, Xiaodong
    Huang, Jing
    Wu, Benquan
    Huang, Xubing
    Zhou, Yuqi
    Zhu, Jiaxin
    Hou, Jinghui
    CANCER SCIENCE, 2008, 99 (11): : 2185 - 2192
  • [25] A nomogram predicting survival of patients (pts) with metastatic or unresectable urothelial cancer (UC) treated with cisplatin-based chemotherapy
    Bajorin, D. F.
    Ostrovnaya, I.
    Iasonos, A.
    Milowsky, M. I.
    Boyle, M.
    Riches, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Comparison of cisplatin-based neoadjuvant chemotherapy for bladder cancer in elderly versus younger patients
    Chau, Caroline Shuet Yiu
    Wheater, Matthew James
    Geldart, Thomas R.
    Crabb, Simon J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] INCIDENCE OF THROMBOEMBOLIC EVENTS IN PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY
    Fernandes, A. C.
    Meireles, S. R.
    Augusto, I.
    Aguas, L.
    Damasceno, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 525 - 526
  • [28] BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer
    Font, A.
    Taron, M.
    Gago, J. L.
    Costa, C.
    Sanchez, J. J.
    Carrato, C.
    Mora, M.
    Celiz, P.
    Perez, L.
    Rodriguez, D.
    Gimenez-Capitan, A.
    Quiroga, V.
    Benlloch, S.
    Ibarz, L.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 139 - 144
  • [29] Amifostine as protective agent in cisplatin-based chemotherapy of advanced bladder cancer
    Heidenreich, A
    Marx, FJ
    Peters, HJ
    UROLOGE-AUSGABE A, 1999, 38 (06): : 586 - 591
  • [30] High risk vascular fingerprint in patients treated with cisplatin-based chemotherapy for testicular cancer
    Lubberts, Sjoukje
    Boer, Hink
    Altena, Renske
    Meijer, Coby
    van Roon, Arie M.
    Zwart, Nynke
    Oosting, Sjoukje
    Kamphuisen, Pieter W.
    Nuver, Janine
    Smit, Andries J.
    Mulder, Andre B.
    Lefrandt, Joop D.
    Gietema, Jourik A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345